|
Sign In to gain access to subscriptions and/or personal tools.
|
Biocompatibility of Poly( -caprolactone) Scaffold Modified by ChitosanThe Fibroblasts Proliferation in vitro
Na Mei
The Key Laboratory of Molecular Engineering of Polymers, Ministry of Education, Macromolecular Science Department, Fudan University, Shanghai 200433, P.R. China
Guang Chen
The Key Laboratory of Molecular Engineering of Polymers, Ministry of Education, Macromolecular Science Department, Fudan University, Shanghai 200433, P.R. China
Ping Zhou
The Key Laboratory of Molecular Engineering of Polymers, Ministry of Education, Macromolecular Science Department, Fudan University, Shanghai 200433, P.R. China, pingzhou{at}fudan.edu.cn
Xin Chen
The Key Laboratory of Molecular Engineering of Polymers, Ministry of Education, Macromolecular Science Department, Fudan University, Shanghai 200433, P.R. China
Zheng-Zhong Shao
The Key Laboratory of Molecular Engineering of Polymers, Ministry of Education, Macromolecular Science Department, Fudan University, Shanghai 200433, P.R. China
Luan-Feng Pan
Laboratory of Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China
Chun-Gen Wu
Laboratory of Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China
In this study, the surface of poly("-caprolactone) (PCL) scaffold was modified by chitosan (CS) in order to enhance its cell affinity and biocompatibility. It is demonstrated by scanning electronic microscopy (SEM) that when 0.5-2.0 wt% chitosan solutions are used to modify the PCL scaffold, the amount of adhesion of the fibroblasts on the chitosan-modified PCL scaffolds dramatically increase when compared to the control after 7 days cell culture. The results indicate that the chitosan-modified PCL scaffolds are more favorable for cell proliferation by improving the scaffold biocompatibility. The improvement may be helpful for the extensive applications of PCL scaffold in heart valve and blood vessel tissue engineering.
Key Words: PCL chitosan porous scaffold modification human fetal lung fibroblast (HFL-1)
Journal of Biomaterials Applications, Vol. 19, No. 4,
323-339 (2005)
DOI: 10.1177/0885328205048630

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Akhyari, H. Kamiya, A. Haverich, M. Karck, and A. Lichtenberg
Myocardial tissue engineering: the extracellular matrix.
Eur. J. Cardiothorac. Surg.,
August 1, 2008;
34(2):
229 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|